Butters rich either in trans-10-C18:1 or in trans-11-C18:1 plus cis-9, trans-11 CLA differentially affect plasma lipids and aortic fatty streak in experimental atherosclerosis in rabbits

Animal

Volumn 1, Issue 3, 2007, Pages 467-476

  Roy, A ^a,b,c   Chardigny, J M ^a,b   Bauchart, D ^c   Ferlay, D ^c   Lorenz, S ^c   Durand, D ^c   Gruffat, D ^c   Faulconnier, Y ^c   Sebedio J L ^a,b   Chilliard, Y ^c  

^a INRA and University of Auvergne   (France)

^b CRNH AUVERGNE   (France)

^c UMR1213 HERBIVORES   (France)

Author keywords

Atherosclerosis; Butter; Conjugated linoleic acid; Rabbits; trans 10 C18:1

Indexed keywords

CONJUGATED LINOLEIC ACID; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MILK FAT; SATURATED FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BUTTER; CARDIOVASCULAR RISK; CONTROLLED STUDY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ORYCTOLAGUS CUNICULUS;

EID: 34047105380     PISSN: 17517311     EISSN: 1751732X     Source Type: Journal    
DOI: 10.1017/S175173110770530X     Document Type: Article

References (43)

1. Barish GD and Evans RM 2004. PPARs and LXRs: atherosclerosis goes nuclear. Trends in Endocrinology and Metabolism 15, 158-165.
2. and Future Forum Editorial Board Barter P, Kastelein J, Nunn A and Hobbs R 2003. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 168, 195-211.
3. Bartlett GR 1959. Phosphorus assay in column chromatography. Journal of Biological Chemistry 234, 466-468.
4. Bauchart D, Durand D, Laplaud PM, Forgez P, Goulinet S and Chapman MJ 1989. Plasma lipoproteins and apolipoproteins in the preruminant calf, Bos spp: density distribution, physiochemical properties, and the in vivo evaluation of the contribution of the liver to lipoprotein homeostasis. Journal of Lipid Research 30, 1499-1514.
5. Bauman DE, Barbano DM, Dwyer DA and Griinari JM 2000. Technical note: production of butter with enhanced conjugated linoleic acid for use in biomedical studies with animal models. Journal of Dairy Science 83, 2422-2425.
6. Chawla A, Repa JJ, Evans RM and Mangelsdorf DJ 2001. Nuclear receptors and lipid physiology: opening the X-files. Science 294, 1866-1870.
7. Chilliard Y and Ferlay A 2004. Dietary lipids and forages interactions on cow and goat milk fatty acid composition and sensory properties. Reproduction Nutrition Development 44, 467-492.
8. Christie WW, Sébédio J-L and Juanéda P 2001. A practical guide to the analysis of conjugated linoleic acid. Inform 12, 147-152.
9. Corl BA, Barbano DM, Bauman DE and Ip C 2003. Cis-9, trans-11 CLA derived endogenously from trans-11 18:1 reduces cancer risk in rats. Journal of Nutrition 133, 2893-2900.
10. De Lorgeril M and Salen P 2004. Use and misuse of dietary fatty acids for the prevention and treatment of coronary heart disease. Reproduction Nutrition Development 44, 283-288.
11. Eder K, Schleser S, Becker K and Korting R 2003. Conjugated linoleic acid lower the release of eicosanoids and nitric oxide from human aortic endothelial cells. Journal of Nutrition 133, 4083-4089.
12. Faulconnier Y, Roy A, Ferlay A, Chardigny J-M, Durand D, Lorenz S, Gruffat D and Chilliard Y 2006. Effect of dietary supply of butters rich either in trans-10-18:1 or in trans-11-18:1 plus cis-9, trans-11-18:2 on rabbit adipose tissue and liver lipogenic activities. British Journal of Nutrition 96, 461-468.
13. Folch J, Lees M and Sloane Stanley GH 1957. A simple method for the isolation and purification of total lipids from animal tissues. Journal of Biological Chemistry 226, 497-509.
14. Hennig B, Toborek M and McClain CJ 2001. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. Journal of American College of Nutrition 20, 97-105.
15. Hodgson JM, Wahlqvist ML, Boxall JA and Balazs ND 1996. Platelet trans fatty acids in relation to angiographically assessed coronary artery disease. Atherosclerosis 120, 147-154.
16. Ip C, Banni S, Angioni E, Carta G, McGinley J, Thompson HJ, Barbano D and Bauman D 1999. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risks in rats. Journal of Nutrition 129, 2135-2142.
17. Kritchevsky D, Tepper SA, Wright S and Czarnecki SK 2002. Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutrition Research 22, 1275-1279.
18. Kritchevsky D, Tepper SA, Wright S, Czarnecki SK, Wilson TA and Nicolosi RJ 2004. Conjugated linoleic acid isomers effects in atherosclerosis: growth and regression of lesions. Lipids 39, 611-616.
19. Lee KN, Kritchevsky D and Pariza MW 1994. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 108, 19-25.
20. Leplaix-Charlat L, Bauchart D, Durand D, Laplaud PM and Chapman MJ 1996. Plasma lipoproteins in preruminant calves fed diets containing tallow or soybean oil with and without cholesterol. Journal of Dairy Science 79, 1267-1277.
21. Libby P, Aikawa M and Schönbeck U 2000. Review: cholesterol and atherosclerosis. Biochimica et Biophysica Acta 1529, 299-309.
22. Lock AL, Horne CAM, Bauman DE and Salter AM 2005. Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein profile in cholesterol-fed hamsters. Journal of Nutrition 135, 1934-1939.
23. Mangiapane EH, McAteer MA, Benson GM, White DA and Salter AM 1999. Modulation of the regression of atherosclerosis in the hamster by dietary lipids: comparison of coconut oil and olive oil. British Journal of Nutrition 82, 401-409.
24. Mensink RP, Zock PL, Kester ADM and Katan MB 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition 77, 1146-1155.
25. Millatt LJ, Bocher V, Fruchart JC and Staels B 2003. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis. Biochimica et Biophysica Acta 1632, 107-118.
26. Mitchell PL, Langille MA, Currie DL and McLeod RS 2005. Effect of conjugated linoleic acid isomers on lipoproteins and atherosclerosis in the Syrian golden hamster. Biochimica et Biophysica Acta 1734, 269-276.
27. Nicolosi RJ, Roger EJ, Kritchevsky D, Scimeca JA and Huth PJ 1997. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 22, 266-277.
28. Oates JA, Fitzgerald GA, Branch RA, Jackson EK, Knapp HR and Roberts LJ 1988. Clinical implications of prostaglandin and thromboxane A2 formation. New England Journal of Medicine 319, 689-698.
29. Peet DJ, Janowski BA and Mangelsdorf DJ 1998. The LXRs: a new class of oxysterol receptors. Current Opinion in Genetics and Development 8, 571-575.
30. Precht D and Molkentin J 1996. Rapid analysis of the isomers of trans-octadecenoic acid in milk fat. International Dairy Journal 6, 791-809.
31. Roy A, Ferlay A and Chilliard Y 2006. Production of butter fat rich in trans-10-C18:1 for use in biomedical studies in rodents. Reproduction Nutrition Development 46, 211-218.
32. Santora JE, Palmquist DL and Roehrig KL 2000. Trans-vaccenic acid is desaturated to conjugated linoleic acid in mice. Journal of Nutrition 130, 208-215.
33. Schuster GU, Parini P, Wang L, Alberti S, Steffensen KR, Hansson GK, Angelin B and Gustafsson JA 2002. Accumulation of foam cells in liver X receptordeficient mice. Circulation 106, 1147-1153.
34. Sébédio J-L, Juanéda P, Grégoire S, Chardigny J-M, Martin J-C and Giniès C 1999. Geometry of conjugated double bonds of CLA isomers in a commercial mixture and in their hepatic 20:4 metabolites. Lipids 34, 1319-1325.
35. Statistical Analysis Systems Institute 1985. SAS user's guide, statistics (fifth edition). SAS Institute Inc., Cary, NC, USA.
36. Terpstra AH 2004. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: an overview of the literature. American Journal of Clinical Nutrition 79, 352-361.
37. Toomey S, Roche H, Fitzgerald O and Belton O 2003. Regression of pre-established atherosclerosis in the apoE 2/2 mouse by conjugated linoleic acid. Biochemical Society Transactions 31, 1075-1079.
38. Torres-Duarte AP and Vanderhoek JY 2003. Conjugated linoleic acid exhibits stimulatory and inhibitory effects on prostanoid production in human endothelial cells and platelets. Biochimica Biophysica Acta 1640, 69-76.
39. Truitt A, McNeill G and Vanderhoek JY 1999. Antiplatelet effects of conjugated linoleic acid isomers. Biochimica Biophysica Acta 1438, 239-246.
40. Turpeinen AM, Mutanen M, Aro A, Salminen I, Basu S, Palmquist DL and Griinari JM 2002. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. American Journal of Clinical Nutrition 76, 504-510.
41. Valeille K, Férézou J, Amsler G, Quignard-Boulangé A, Parquet M, Gripois D, Dorovska-Taran V and Martin J-C 2005. A cis-9, trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. American Journal of Physiology, Heart and Circulatory Physiology 289, H652-H659.
42. Wahle KW, Heys SD and Rotondo D 2004. Conjugated linoleic acids: are they beneficial or detrimental to health? Progress on Lipid Research 43, 553-587.
43. Wilson TA, Nicolosi RJ, Chrysam M and Kritchevsky D 2000. Conjugated linoleic acid reduces early aortic atherosclerosis greater than linoleic acid in hypercholesterolemic hamsters. Nutrition Research 20, 1795-1805.